2 June 2026 in ANNALS OF ABBASI SHAHEED HOSPITAL AND KARACHI MEDICAL & DENTAL COLLEGE
Objectives: The purpose of the study was to determine the prevalence of biofilm production and resistance to several antibiotics in P. aeruginosa isolated from post-surgical wound infections at a tertiary hospital. It also investigated the relationship between biofilm formation and drug resistance.Methods: The research was a cross-sectional study carried out between November 2024 and October 2025 on 116 non-duplicate P. aeruginosa isolates in patients with clinically diagnosed PSWIs. Standard microbiological techniques were used to identify isolates. The Kirby-Bauer disk diffusion technique was used to test antimicrobial susceptibility according to CLSI 2024 standards. The Tissue Culture Plate (microtiter plate) method was used to quantitatively measure biofilm production. Thestatistical analysis was conducted with SPSS 26.0, and the p-value was considered significant below 0.05.Results: Polymyxins (colistin and polymyxin B) exhibited the highest susceptibility rates (96.6% and 94.8%, respectively), while the lowest susceptibility was observed against ciprofloxacin (44.0%). Overall, 52 (44.8%; 95% CI: 35.9–53.9%) isolates were MDR, and 18 (15.5%; 95% CI: 9.5–23.5%) were XDR. Biofilm production was detected in 93 (80.2%) isolates, with 24 (20.7%) classified as strong producers. Using the Chi-square test for trend, we found a statistically significant relationship between biofilm formation and MDR (p < 0.001), with strong biofilm producers exhibiting markedly higher resistance to multiple antibiotics, including ciprofloxacin (87.5%) and meropenem (62.5%).Conclusion: The study shows high biofilm production and resistance to antimicrobials (MDR and XDR) of P. aeruginosa in post-surgical wound infections (PSWIs). This observation reveals a therapeutic dilemma, which suggests screening for biofilm and judicious use of antibiotics, along with adjunct therapies, such as biofilm-disrupting agents, to treat PSWIs.
1 January 2025 in Medical and Pharmaceutical Journal
Background: Parkinson's disease is a chronic central nervous system disorder that is primarily marked by motor symptoms, which include tremor, decreased movement, muscle rigidity, and loss of balance. Impulse Control Disorders (ICDs) are serious non-motor side effects associated with dopamine agonist (DA) therapy in Parkinson’s disease (PD). Objective: This study investigated the structural and functional neural correlates of ICDs in PD patients on DA treatment using multimodal neuroimaging. Methods: Sixty participants (30 with ICDs, 30 matched controls) underwent clinical assessments, structural MRI, resting-state fMRI, and task-based fMRI during a monetary incentive delay task. Results: Structural MRI revealed reduced grey matter volume in the right orbitofrontal cortex (OFC) in the ICD group. Resting-state fMRI showed hyperconnectivity between the nucleus accumbens (NAcc) and medial prefrontal cortex (mPFC), and reduced anticorrelation between the OFC and dorsal anterior cingulate cortex (dACC). Task-based fMRI demonstrated blunted ventral striatal activation during reward anticipation but heightened OFC activation during outcome processing. Conclusion: These multimodal findings support a model of ICDs involving both reward system hyperactivity and impaired inhibitory control. The combined use of structural, resting-state, and task-based fMRI in the same cohort offers novel insights and potential biomarkers for early detection and targeted interventions.